Side-by-side comparison of AI visibility scores, market position, and capabilities
US YC W20 AI Medicare guidance platform launched Vox in Aug 2024; conversational AI for 67M Medicare beneficiaries navigating plan selection and enrollment competing with GoHealth for 24/7 AI-first Medicare Advantage and Supplement comparison.
Medicare Vox (formerly Fair Square Medicare) is a United States-based AI-powered Medicare insurance guidance platform — backed by Y Combinator (W20) — providing Medicare beneficiaries and their families with 24/7 conversational AI-powered assistance for Medicare plan selection, enrollment navigation, and claims guidance through its Vox platform launched in August 2024. Originally founded in 2019 as Fair Square Medicare — a licensed insurance agency helping seniors compare and enroll in Medicare Advantage and Medicare Supplement (Medigap) plans — the company rebranded and launched the Vox AI platform to scale Medicare beneficiary support beyond the capacity of human insurance agents, addressing the complex decision-making that Medicare's 67 million enrollees face when choosing among hundreds of available plans during the annual Open Enrollment Period.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.